INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$21K
5,500 sh
Nov 24, 2025Nov 25, 2025
Page 1756 of 1855
← PrevNext →
traded Nov 24, 2025
+1d
SEC Form 4

Evidence

2
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$67K
17.8K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

0
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
4,594 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

0
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$2,293
605 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
906 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

0
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
10.0K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$7,270
38.9K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

0
HJ
Herrington Douglas JCEO Worldwide Amazon Stores
AMZNAMAZON COM INC
Option exercise · 10b5-1 plan
M—
3,500 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
SS
Sharan SharatDirector, President and Chief Executive, 10% Owner
ONTFON24 INC.
Option exercise · 10b5-1 plan
M—
53.5K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

0
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$30K
8,000 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
HJ
Herrington Douglas JCEO Worldwide Amazon Stores
AMZNAMAZON COM INC
Option exercise · 10b5-1 plan
M—
3,827 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
HJ
Herrington Douglas JCEO Worldwide Amazon Stores
AMZNAMAZON COM INC
Option exercise · 10b5-1 plan
M—
3,827 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
HJ
Herrington Douglas JCEO Worldwide Amazon Stores
AMZNAMAZON COM INC
Option exercise · 10b5-1 plan
M—
9,760 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
HJ
Herrington Douglas JCEO Worldwide Amazon Stores
AMZNAMAZON COM INC
Option exercise · 10b5-1 plan
M—
9,760 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
2,500 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
605 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
SS
Sharan SharatDirector, President and Chief Executive, 10% Owner
ONTFON24 INC.
Option exercise · 10b5-1 plan
M$48K
53.5K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

0
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
5,500 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

0
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$17K
100.0K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

0
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$3,434
906 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

0
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$17K
4,594 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
2,500 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

60
Xu TonyDirector, CHIEF EXECUTIVE OFFICER, 10% Owner
DASHDoorDash, Inc.
Open-market sale
SELL$55.51M
283.0K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

57
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$6.66M
38.6K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

54
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$617K
3,560 sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

53
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$5.85M
34.0K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

53
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$4.95M
29.0K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

51
TM
Tappin MatthewPresident, Software Products
STEMSTEM, INC.
Open-market sale
SELL$170K
9,584 sh
Nov 11, 2025Nov 24, 2025
traded Nov 11, 2025
+13dSEC Form 4

Evidence

50
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$5.99M
38.3K sh
Nov 21, 2025Nov 24, 2025
traded Nov 21, 2025
+3dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$5.92M
37.4K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$1.51M
8,864 sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$2.86M
18.3K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
IR
Inukonda RaviCHIEF FINANCIAL OFFICER
DASHDoorDash, Inc.
Open-market sale
SELL$3.13M
15.9K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$1.13M
6,749 sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$1.46M
8,921 sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$6.03M
38.4K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$2.39M
14.9K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$2.77M
17.4K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
CA
Cohen Stephen AndrewDirector, See Remarks
PLTRPalantir Technologies Inc.
Open-market sale
SELL$2.96M
19.1K sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence

49
ST
Sherringham TiaGENERAL COUNSEL AND SECRETARY
DASHDoorDash, Inc.
Open-market sale
SELL$1.80M
9,154 sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC Form 4

Evidence